
Conference Coverage
Latest Content

Menopausal Hormone Therapy Linked With Breast Cancer Risk Only When Progestin Is Involved

Heart Benefits of GLP-1 Medications Fade Shortly After Stopping Therapy

Factual Messaging and Clinician Voices Key to Vaccine Social Media Engagement

Racial Disparities Persist in Curative Treatment for Early-Stage NSCLC Among Medicare Beneficiaries

Clonal Hematopoiesis Is Quietly Reshaping CLL Treatment

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Patients with multiple sclerosis valued both occupational therapy and physiotherapy as means of addressing their condition.

Study supports broader use of transient elastography to detect advanced liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease.

Icotrokinra is the first and only interleukin-23–targeted oral peptide approved for plaque psoriasis.


Smarter therapies, evolving frailty tools, and more inclusive trials are finally extending myeloma's survival gains to older adults.

A federal court blocked RFK Jr's vaccine agenda, freezing the ACIP shakeup and safeguarding child vaccine access as the legal fight over vaccines intensifies.

Many hospitalized adults could benefit from linkage to dental care. This article describes a planned study to refer inpatients to community dental providers.


Long-term adherence to healthy behaviors reduces the risk of cardiovascular disease and type 2 diabetes, even among individuals taking antihypertensive medications.

The complete response letter marks the second time that reproxalap, a medication for use in dry eye disease, has been rejected by the FDA.









































